Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar A Santa-Maria

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|September 16, 2020
Landmark trials in the medical oncology management of early stage breast cancerWhitney Hensing, Cesar A Santa-Maria, Lindsay L Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based ConsiderationsCesar A Santa-Maria, Maureen O'Donnell, Raquel Nunes, et al.
Science Advances|June 30, 2023
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibitionTheinmozhi Arulraj, Hanwen Wang, Leisha A Emens, et al.
Iscience|July 20, 2022
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancerHanwen Wang, Chen Zhao, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|March 31, 2023
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisisJoyce M Cheng, Jenna Canzoniero, Seoho Lee, et al.
Cancer Medicine|August 7, 2020
Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapySarah Talamantes, Eric Xie, Ricardo L B Costa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Breast Cancer Research and Treatment|June 1, 2018
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapySarika Jain, Ami N Shah, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|April 13, 2019
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancerMartin Mutonga, Sedona Speedy, Alfred Rademaker, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|September 16, 2020
Landmark trials in the medical oncology management of early stage breast cancerWhitney Hensing, Cesar A Santa-Maria, Lindsay L Peterson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2022
Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based ConsiderationsCesar A Santa-Maria, Maureen O'Donnell, Raquel Nunes, et al.
Science Advances|June 30, 2023
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibitionTheinmozhi Arulraj, Hanwen Wang, Leisha A Emens, et al.
Iscience|July 20, 2022
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancerHanwen Wang, Chen Zhao, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|March 31, 2023
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisisJoyce M Cheng, Jenna Canzoniero, Seoho Lee, et al.
Cancer Medicine|August 7, 2020
Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapySarah Talamantes, Eric Xie, Ricardo L B Costa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 10, 2024
Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerHaoyang Mi, Ravi Varadhan, Ashley M Cimino-Mathews, et al.
Breast Cancer Research and Treatment|June 1, 2018
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapySarika Jain, Ami N Shah, Cesar A Santa-Maria, et al.
Breast Cancer Research and Treatment|April 13, 2019
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancerMartin Mutonga, Sedona Speedy, Alfred Rademaker, et al.
Pageof 6